MAPK3 and cancer: Given the association of FOSL1 with elevated ERK1/2 activity and cancer cell invasion [28, 29], we conducted gain-of-function assays with phosphomimetic mutants of FOSL1 and RELA (Fig. 4d, Supplementary Materials 1 and 2).